Publications

NAFB001

"A synthetic peptide from transforming growth factor b type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury".

Ignacio-José Ezquerro, Juan-José Lasartea, Javier Dotor, Inma Castilla-Cortázar, Matilde Bustos, Iván Peñuelas, Gemma Blanco, Carlos Rodríguez, María del Carmen G. Lechuga, Patricia Greenweld, Marcos Rojkinde, Jesús Prieto, Francisco Borrás-Cuesta.

Cytokine. 2003 Apr;22(1-2):12-20.

Abstract

“Topical application of a TGF-b1 receptor III derived TGF-b1 antagonistic peptide ameliorates bleomycin induced fibrosis”

Begoña Santiago, Irene Gutierrez-Cañas, Javier Dotor, Guillermo Palao, Juan Ruiz, Francisco Borras, José L. Pablos

Journal of Investigative Dermatology

“The use of the transforming growth factor-b1 inhibitor peptide in periprosthetic capsular fibrosis: experimental model with tetraglycerol-dipalmitate”

R. Ruiz-de-Erenchun, M.D.*, J. Dotor de las Herrerías,Ph.D.**, B. Hontanilla, M.D., PhD. *

* Department of Plastic, Reconstructive and Aesthetic Surgery, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain.

** Laboratory of Internal Medicine, School of Medicine, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain.

Presented in XV Congress of the Iberolatinoamerican Federation of Plastic and Reconstructive Surgery (FILACP) and the XXXIX Congress of the Spanish Society of Plastic, Reconstructive and Esthetic Surgery (SECPRE). Sevilla, Spain. May 2004.

<< Volver